SEC 13F Intelligence

Ctc Alternative Strategies, Ltd. / GILD

Ctc Alternative Strategies, Ltd.’s Gilead Sciences Inc Position

Does Ctc Alternative Strategies, Ltd. own Gilead Sciences Inc (GILD)? Not currently — the last reported position was 9.1K shares worth $1M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q4 2025
Shares
9.1K
% of Portfolio
+2.09%
Quarters Held
4
position exited

Position History GILD

Reported value by quarter
Q2 ’24: $412,621Q2 ’24Q1 ’25: $784,350Q1 ’25Q2 ’25: $853,699Q2 ’25Q4 ’25: $1MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20259.1K$1M+2.09%
Q2 20257.7K$853,699+0.75%
Q1 20257.0K$784,350+0.96%
Q2 20246.0K$412,621+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ctc Alternative Strategies, Ltd.’s full portfolio or all institutional holders of GILD.